Role of nitric oxide/cyclic GMP in i.c.v. administered β-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse

European Journal of Pharmacology

Volumn 262, Issue 3, 1994, Pages 223-231

  Yu Xu, Jimmy ^a   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

(+) cis Dioxolane; Antinociception; cGMP; Nitric oxide (NO); Tail flick inhibition; Endorphin

Indexed keywords

1,3 DIOXOLANE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ARGININE; BETA ENDORPHIN; BUCLADESINE; CARBACHOL; CYCLIC GMP; DELTA OPIATE RECEPTOR; DEXTRO ARGININE; DIBUTYRYL CYCLIC GMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; EPSILON OPIATE RECEPTOR; HEMOGLOBIN; KAPPA OPIATE RECEPTOR; METHYLENE BLUE; MORPHINE; MU OPIATE RECEPTOR; MUSCARINIC AGENT; N(G) NITROARGININE; NITRIC OXIDE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESIA; ANALGESICS; ANIMAL; ARGININE; BETA-ENDORPHIN; CYCLIC GMP; DIOXOLANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; HEMOGLOBINS; INJECTIONS, INTRAVENTRICULAR; MALE; METHYLENE BLUE; MICE; MICE, INBRED ICR; MORPHINE; NITRIC OXIDE; NITROARGININE; PYRROLIDINES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; STEREOISOMERISM; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028124513     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)90736-6     Document Type: Article

References (42)

1. Antinociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA
2. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme
3. Localization of nitric oxide synthase indicating a neural role for nitric oxide
4. Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures
5. Guanosine 3′,5′-monophosphate, a central nervous system regulator of analgesia
6. A method for determining loss of pain sensation
7. Endogenous activity factor for guanylate cyclase in synaptosomal soluble fraction of the rat brain
8. The molecular mechanism of central analgesia induced by morphin or carbachol and the L-arginine-nitric oxide-cGMP pathway
9. Glutamate, nitric oxide and cell-cell signalling in the nervous system
10. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
11. 2 biochemical and functional characterization
12. Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3′,5′-monophosphate
13. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions
14. Nitric oxide mediates cholinergic antinociception in rats
15. Nitric oxide mediated muscarinic analgesia: sites of nitric oxide synthase and guanylyl cyclase mRNA-containing neurons in rat rostral medulla
16. Possible involvement of nitric oxide in arginine-induced analgesia
17. Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opiodergic systems
18. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway
19. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase
20. Regional sensitivity of cyclic AMP and cyclic GMP in rat brain to central cholinergic stumulation
21. β-Endorphin is a potent analgesic agent
22. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta
23. Polymethylene tetramines: a new generation of selective muscarinic antagonists
24. Activation of cerebral guanylate cyclase by nitric oxide
25. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication
26. Nitric oxide: physiology, pathophysiology, and pharmacology
27. g-Nitro arginine methyl ester exhibits antinociceptive activity in the mouse
28. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure
29. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indales: antinociceptive and cardiovascular effects
30. G-nitro-arginine methyl ester-induced antinociception in mice: a role for serotonergic and adrenergic neurons
31. Comparison of descending pain inhibitory pathways activated by β-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice
32. A requirement for intercellular messenger nitric oxide in long-term potentiation
33. Nitric oxide as a neuronal messenger
34. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice
35. Delta- but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice
36. Differential mechanisms mediating β-endorphin and morphine-induced analgesia in mice
37. cGMP formation and phosphoinositide turnover in rat brain slices are mediated by pharmacologically distinct muscarinic acetylcholine receptors
38. Intrathecal Met-enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice
39. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats
40. Increasing of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse
41. Antinociceptive action of the butyryl derivatives of guanosine 3′,5′-cyclic monophosphate
42. Increase of nitric oxide by L-arginine potentiates β-endorphin- but not μ-, δ- or κ-opioid agonist-induced antinociception in the mouse